STAT October 17, 2024
Blue Note’s failure holds lessons for other digital therapeutics startups
The bad news didn’t come all at once for Blue Note Therapeutics, but a final denial from the Food and Drug Administration in January proved to be the final blow.
In late 2023, after a rejection from the agency earlier in the year, Blue Note had made a last...